NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation

Conditions:   Non-Alcoholic Fatty Liver Disease;   Chronic Kidney Diseases;   PreDiabetes;   Kidney Transplant Interventions:   Diagnostic Test: MR spectroscopy of the liver;   Diagnostic Test: Fibroscan of the liver;   Device: Continuous glucose monitoring (CGM) for four days.;   Diagnostic Test: Oral glucose tolerance test (OGTT);   Diagnostic Test: Intra venous glucose infusion (IIGI);   Radiation: Dua l Energy X-ray Absorptiometry (DEXA) scan;   Biological: Blood samples;   Other: Clinical and demographic data Sponsors:   Rigshospitalet, Denmark;   Steno Diabetes Center;   Herlev and Gentofte Hospital;   The Novo Nordisk Foundation Center for Basic Metabolic Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials